WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsClaritev Corporation (CTEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 1237% more annual revenue ($12.91B vs $965.41M). BTSG leads profitability with a 1.5% profit margin vs -29.4%. BTSG earns a higher WallStSmart Score of 54/100 (C-).

BTSG

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 3.0Quality: 7.5
Piotroski: 5/9Altman Z: 2.62

CTEV

Avoid

33

out of 100

Grade: F

Growth: 4.0Profit: 3.5Value: 5.0Quality: 5.5
Piotroski: 4/9Altman Z: -0.38
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BTSGSignificantly Overvalued (-78.4%)

Margin of Safety

-78.4%

Fair Value

$22.46

Current Price

$44.82

$22.36 premium

UndervaluedFair: $22.46Overvalued

Intrinsic value data unavailable for CTEV.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
29.3%8/10

Revenue surging 29.3% year-over-year

CTEV1 strengths · Avg: 10.0/10
Debt/EquityHealth
-45.6910/10

Conservative balance sheet, low leverage

Areas to Watch

BTSG4 concerns · Avg: 3.3/10
EPS GrowthGrowth
3.4%4/10

3.4% earnings growth

Return on EquityProfitability
5.9%3/10

ROE of 5.9% — below average capital efficiency

Profit MarginProfitability
1.5%3/10

1.5% margin — thin

Operating MarginProfitability
3.0%3/10

Operating margin of 3.0%

CTEV4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$246.47M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-6.5%2/10

ROE of -6.5% — below average capital efficiency

Altman Z-ScoreHealth
-0.382/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.

Bull Case : CTEV

The strongest argument for CTEV centers on Debt/Equity.

Bear Case : BTSG

The primary concerns for BTSG are EPS Growth, Return on Equity, Profit Margin. A P/E of 90.2x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.

Bear Case : CTEV

The primary concerns for CTEV are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

BTSG profiles as a growth stock while CTEV is a turnaround play — different risk/reward profiles.

BTSG carries more volatility with a beta of 2.33 — expect wider price swings.

BTSG is growing revenue faster at 29.3% — sustainability is the question.

BTSG generates stronger free cash flow (174M), providing more financial flexibility.

Bottom Line

BTSG scores higher overall (54/100 vs 33/100) and 29.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.

Visit Website →

Claritev Corporation

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Claritev Corporation, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?